Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
University Hospital, Strasbourg, France |
---|---|
Information provided by: | University Hospital, Strasbourg, France |
ClinicalTrials.gov Identifier: | NCT00213902 |
The objectives of this study are:
The study is a double-blind, placebo-controlled study evaluating the effects of clonidine compared to placebo in patients with DHF. A total of 70 patients with DHF will be randomized in a 1:1 ratio to:
The primary outcome is the reversion of cardiac remodeling and hemodynamic parameters evaluated by magnetic resonance imaging (MRI) and echocardiography.
Study Type: | Observational |
Study Design: | Prospective |
Official Title: | Evaluation of Effects of Central Sympathetic Inhibition in Elderly With Left Ventricular Diastolic Dysfunction and Preserved Ejection Fraction: A Proof-of-Concept Trial With Clonidine |
Ages Eligible for Study: | 60 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Study ID Numbers: | 3153 |
Study First Received: | September 13, 2005 |
Last Updated: | November 28, 2007 |
ClinicalTrials.gov Identifier: | NCT00213902 History of Changes |
Health Authority: | France: Afssaps - French Health Products Safety Agency |
Heart failure Diastolic functionClonidine Left ventricular diastolic dysfunction with preserved ejection fraction |
Ventricular Dysfunction Heart Failure Heart Diseases Clonidine Ventricular Dysfunction, Left |
Ventricular Dysfunction Heart Diseases Ventricular Dysfunction, Left Cardiovascular Diseases |